BBA
WINT

Baker Bros. Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

Baker Bros. Advisors’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-254,973
Closed -$291K – 124
2017
Q1 		$291K Hold
254,973
– – ﹤0.01% 116
2016
Q4 		$319K Hold
254,973
– – ﹤0.01% 128
2016
Q3 		$653K Hold
254,973
– – 0.01% 122
2016
Q2 		$492K Hold
254,973
– – 0.01% 127
2016
Q1 		$426K Sell
254,973
-2
-0% -$4 ﹤0.01% 127
2015
Q4 		$764K Hold
254,975
– – 0.01% 124
2015
Q3 		$1.07M Hold
254,975
– – 0.01% 118
2015
Q2 		$2.43M Hold
254,975
– – 0.02% 96
2015
Q1 		$4.25M Sell
254,975
-5,891
-2% -$116K 0.04% 81
2014
Q4 		$4.24M Hold
260,866
– – 0.04% 76
2014
Q3 		$6.72M Hold
260,866
– – 0.08% 53
2014
Q2 		$6.5M Hold
260,866
– – 0.08% 60
2014
Q1 		$7.85M Sell
260,866
-4,750
-2% -$160K 0.1% 54
2013
Q4 		$8.37M Buy
265,616
+157,143
+145% +$4.91M 0.12% 52
2013
Q3 		$2.98M Hold
108,473
– – 0.04% 68
2013
Q2 		$2.31M Buy
+108,473
New +$2.67M 0.05% 60

Other funds holding WINT

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Baker Bros. Advisors's WINT Position: Q2 2017 in Review

Baker Bros. Advisors sold out of Windtree Therapeutics Inc (WINT) in Q2 2017, closing a stake of 254,973 shares — an estimated $291K sold.

Baker Bros. Advisors first reported a position in WINT in Q2 2013 and held it in 16 quarters. The position peaked at $8.37M in Q4 2013. 3 funds tracked by Wall St. Rank hold WINT as of Q2 2017.

  • Baker Bros. Advisors reported no remaining Windtree Therapeutics Inc position as of Q2 2017 after selling out during the quarter.
  • Baker Bros. Advisors sold 254,973 Windtree Therapeutics Inc shares in Q2 2017, an estimated $291K.
  • Baker Bros. Advisors first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 16 quarters.
  • Baker Bros. Advisors's Windtree Therapeutics Inc position peaked at $8.37M in Q4 2013.
  • 3 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2017.

Based on Baker Bros. Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.